Professional Documents
Culture Documents
Ilovepdf Merged PDF
Ilovepdf Merged PDF
Procedure
Before commencement of validation tasks copy documents listed in the following tables. The following
documents are required.
Document
Document Name Sign/Date
Number
Conduct all tests indicated. Attach all documents to this protocol. Any deviations raised during validation
must be recorded using Form-745 (Protocol Deviations/Deficiencies Report).
Sign/Date
Before commencement of the operational verification, Documentation Verification and
Cycle Review Form-765) must be completed and attached.
Table 2. Signatories
System Owner
Engineering and
Engineering
Maintenance Manager
1.3.2 Conduct a Vacuum Leak Test using Form-805 (Vacuum Leak Test). Record all test instances
conducted in Table 3.
Deviation Number
Date (if applicable) Sign/Date
a
Sign/Date
1.3.3 Perform an initial Steam Penetration/Air Removal (Bowie Dick) Test using Form-
790 (Steam Penetration/Air Removal (Bowie Dick) Test).
Sign/Date
1.3.4 Conduct a Heat Penetration and Heat Distribution Study for EACH cycle using
VAL-180 (Heat Penetration and Heat Distribution Study) as listed in Table 1.
2. Completion
Upon completion of this protocol all executed test sheets must be attached and a report must be written (Ref
VAL-175).
3. Signature Verification
Designated personnel assigned the responsibility of executing or reviewing execution of this document will
sign, initial and date the corresponding sections in Table 3.
Table of Contents
1 Introduction ................................................................................................................................... 2
2 Responsibilities ............................................................................................................................. 3
4 References .................................................................................................................................. 12
2 Responsibilities
QC Laboratory
Development
Development
QC Manager
Engineering
Engineering
Production
Production
Assurance
Validation
Validation
Manager
Manager
Manager
Manager
Manager
Quality
Quality
Validation study design P P I I I I I I I I I I
Identifying and providing the appropriate level of resource in order
to execute the cleaning validation exercises P P (P) (P) (P) (P) (P)
Identification of process equipment trains and selection of worst
case products for validation P/A P I I I I I I I I I/A I
Calculation of cleaning limits for equipment / processes P/A P I I I A I
Training of Operators in Cleaning SOPs I I P P
Writing and execution of protocols P/A P I I A/I I I I I I A/I I
Review of QC results and final report writing P/A P A A
Rinse and Swab Sampling P P I A I I
Conduct analytical test method validation (P)/A/I (P) P/A/I P A/I
Testing of swab and rinse samples (P) I/(P) I I A/P P
Validation cleaning studies discrepancy resolution P/A P I I I I I I I I A/I A/I
Update of this CVMP when required P P I A/I I I A/I
Where A = Approver P = Primary Ownership (P) = Joint Ownership I = Input
3.5.1 A risk-based matrix approach will be used to determine the worst-case product for each cleaning
procedure. Cleaning validation will be performed for all equipment cleaning procedures associated
with that worst-case (highest risk) product. Acceptable validation of a cleaning procedure for the
worst-case product shall constitute validation for all other products that utilise the same cleaning
procedure. Cleaning validation will be performed on additional products, as necessary, to verify
performance of any cleaning procedures relating to equipment, which was not utilized during the
manufacture of the worst-case product.
3.5.2 The risk-based matrix takes into account the following factors (refer Diagram “Risk Matrix”):
Solubility – solubility of the active ingredients in water, as noted in the Merck Index.
Toxicity and Concentration – either based on available toxicology information or based on LD50
Oral (rat) - the amount of a substance required to kill half a given population and percentage of the
active ingredients in the formulation residue.
3.5.3 Carry- over calculations for the permissible residue quantities will be based upon available
toxicology information for the identified substance(s) of greatest toxicity, highest potency or
suitability as in indicating agent for common production equipment.
3.5.4 Swab analysis will generally be performed using the most difficult to remove active drug substance
or the most toxic substance, whichever is determined to be of greatest cross-contamination risk. The
most difficult to remove substance must be identified based on a combination of solubility in the
cleaning agent, and also on first hand experience. In instances where the most potent active used to
calculate the acceptance is potentially harmful as a contaminant in other products, swabbing for
residues of this active will be conducted as well as on the identified worst case (most difficult to
clean active) as an added precaution.
3.5.5 Where swabbing is performed on a worst case active, the acceptance criteria will still be based on
the most potent active, not the active being swabbed. This combination provides a high level of
Copyright©www.gmpsop.com. All rights reserved
Unauthorized copying, publishing, transmission and distribution of any part of the content by electronic
means are strictly prohibited. Page 6 of 12
Standard Operating Procedure
Title: Cleaning Validation Master Plan – Non Sterile Solid
The microbiological acceptance criteria for Total Plate Count (TPC) is based on a maximum allowable count
of 1/cm2 as for swabs and expressed as maximum count per 100mL for each sampling point.
Swabs
TPC: 1 cfu / cm2
Yeast & Mould: 1 cfu / cm2
Pseudomonas spp.: Not Detected/ swab
Coliforms: Not Detected/ swab
E.coli: Not Detected/ swab
Salmonella spp Not Detected/ swab
a) Less than, or equal to, 1 cfu per cm2 for product contact surfaces.
3.9.1.2 Schedules must be prepared listing line/equipment (groups) train, product(s) or product group(s),
and SOP(s) or procedure(s).
3.9.1.3 The following minimum documentation should be available for review on the completion of validation:
cleaning validation protocol, including location maps of swab sampling
published cleaning procedure used in the validation
validation report referenced to raw data
reference to method validation and active product surface recovery studies
Clean hold times will be evaluated where the equipment or system is considered to be at risk of change of
the cleanliness state when left idle for extended periods of time. Equipments or systems have acceptable
hold times evaluated via microbiological or chemical testing as appropriate. Where equipment is sterilised
prior to use, a validated overkill sterilisation cycle for the equipment or system would be considered sufficient
justification to negate the necessity for microbiological evaluation of a hold time. The requirement to conduct
The risk assessment reviews the risks associated with the cleaning
program i.e. what level of cleaning needs to be achieved, toxicity of
Risk Assessment (Protocol)
actives, worse case scenarios of cross contamination potential.
Clean Limit – Rational for setting A limit for acceptable level of “clean”, which is defined in the cleaning
Limit validation protocol, and defined in terms of (a) maximum carryover
levels to the next product and (b) allowable residues per unit are of
equipment surface.
Impact on
Document Validation
Description of Change/Deviation/Maintenance
Number (Yes/No)
1. Procedure
Conduct SOP, Change Control, Deviation, Preventative and Corrective Maintenance reviews as
described in VAL-175 (Validation of Autoclave, Autoclave Loads and Cycles).
1.1.2 Conduct a review of all change controls, deviations, preventative and corrective
maintenance logs using Form-775 (Change Control, Deviation, Preventative and Corrective
Maintenance Summary) Sheet.
Yes/No Sign/Date
Yes/No Sign/Date
1.1.4 Have any deviations been raised?
Yes/No Sign/Date
1.1.5 Have any preventative maintenance been undertaken?
Yes/No Sign/Date
1.1.6 Have any corrective maintenance been undertaken?
If yes, conduct cycle and load review and describe in Form-770 (Validation Cycle Review).
Yes/No Sign/Date
Attach Review to this document
2. Completion
Matrix Review
1. Procedure
Sign/Date
1.1.2 Complete a list of test equipment used (Table 1). Attach a copy of
calibration certificates to this document.
Sign/Date
1.1.3 Calibrate thermocouples (VAL-210). Copy Calibration Verification Record
(Form 825) and attach to this document.
Sign/Date
1.1.4 Sign and attach all printouts of the thermocouple calibrations to this
document.
2. Completion
Upon completion of this test attach document to the Autoclave Validation Protocol (Form 780).
Acceptable Verification
Action (Yes/No) Sign/Date Sign/Date
All cycle parameters are set correctly
Pressure Regulated @
Control Method
212.3kPa (122.0°C)
Holding Time
WET: Sterilisation (Load Probe 2) ≥ 35
(min)
Delay (s) 1
Acceptable Verification
Action (Yes/No) Sign/Date Sign/Date
All cycle parameters were set correctly
and match the print out from the
Autoclave.
1. Procedure
A Vacuum Leak Test is performed to test the integrity of the autoclave. This form must be printed
for each consecutive test.
Sign/Date
1.1.1 Synchronise the time of the Graphic Recorder (Eurotherm Chessell 6000
Multichannel Graphic Recorder) to within 1 minute of the autoclave.
1.1.2 With the autoclave in standby state and the side door slightly open, install Sign/Date
the test equipment (thermocouple harness, independent pressure
measurement device) onto the autoclave validation port(s) located on the
side of the autoclave.
Cycle Number
1.1.3 Perform a Vacuum Leak Test and record cycle
number.
Yes/No
Was test conducted successfully without alarm?
If no, fill out Vacuum Leak Test Summary table in Deviation Number
Autoclave Validation Protocol (Form-780 Autoclave
Validation Protocol), record deviation number and
repeat test again (Note: upon retest print off this form
Sign/Date
1.1.4 Retrieve the autoclave printout(s) and chart recorder trace, sign all
printouts and attach to this document.
2. Completion
Upon completion of this test attach document to the Autoclave Validation Report.
∆P = Final Vacuum
Calculate the ∆P for the
= (Pressure – Initial
Vacuum Hold Phase. ∆P =
Vacuum Pressure).
∆P is ≤3.5 kPa
The cycle Yes/N
completed o
The cycle is completed with no alarm
with NO alarm conditions.
conditions. The Printo
Retrieve the autoclave
autoclave
printout and chart
The autoclave printout recorded a
recorder chart, label and
displays a reading of reading of
attach as specified in the
“CYCLE COMPLETED”. ‘Cycle
test procedure.
Completed’.
The printout and chart The printout Chart
recorder chart are and chart
stamped and attached. recorder are
stamped and
attached.
1. Objective
This test is to be completed once in order to confirm the qualified state of the autoclave for air removal.
2. Procedure
Sign/Date
2.1 Ensure that a Vacuum Leak Test has been successfully completed.
Sign/Date
2.2 Place the Bowie Dick Pack in the chamber and perform Bowie Dick
Cycle.
Cycle Number
Sign/Date
2.5 Retrieve the indicator card and complete Table 1.
Figure 1. Test sheet BEFORE processing Figure 2. Test sheet showing PASS condition
(Blue colour) (Pink colour)
Sign/Date
2.6 Complete End Cycle Checks (Table 2).
The process record, chart recorder print out, indicator card and
picture has been attached to the protocol.
Sign/Date
2.8 Attach a picture of the test sheet result to this document.
3. Completion
Upon completion of this test attach all documentation to the Validation Protocol.
Autoclave
Project Number Number
1. OBJECTIVE
Using a Heat Penetration Study, demonstrate that each of the proposed cycles will, with a high degree of
assurance, sterilise a defined load configuration for the worst-case load. Similarly, conduct a Heat
Distribution Study simultaneously to determine the cold spots and uniformity of heating in the loaded
autoclave chamber.
Load Description
2. PROCEDURE
2.1.1 Synchronise the time of the Graphic Recorder (Eurotherm Chessell 6000 Sign/Date
Multichannel Graphic Recorder) to within 1 minute of the autoclave.
2.1.2 Ensure pre-cycle checks have been successfully performed. Record in Table 1.
2.3.1 Verify that the recorded cycle parameters are consistent with the Sign/Date
programmed cycle parameters. Attach the completed form(s) to this
document.
2.3.2 Retrieve each exposed BI from the load. Submit the exposed and control Sign/Date
BIs with Biological Indicator Test Results Sheet (Form-850) to Quality
Control for sterility testing.
2.3.3 Attach all autoclave printouts and graphs to this document. Sign/Date
2.3.4 Record whether the test has met the acceptance criteria using either Form- Sign/Date
835 Autoclave Cycle Acceptance Criteria. Attach the completed form to this
document.
3. COMPLETION
Upon completion of test, attach this document to Form-780 Autoclave Validation Protocol.
4. REFERENCED DOCUMENTS
Procedure
Fill out table and transfer sheet to Quality Control with all samples.
1. To activate the media, place the indicator in an upright position in a plastic crusher. Gently squeeze the
crusher to break the glass ampoule. Place the activated indicator in the incubator rack and incubate
immediately.
2. Examine the indicator for any colour change at 24h. Record the examining time and results in the table.
Control
Operator Initial/Date
Test Result: Pass Fail
Comment:
Tested By/Date
Verified By/Date
Acceptance Criteria
Achieved
Acceptance Criteria (Yes/No/Accepted under
deviation or N/A)
Recorded cycle parameters are consistent with programmed cycle parameters.
The Department of Agriculture (DoA) requirements are met for DoA regulated loads. (If load
core measured, all points ≥121°C for 15min, else all points ≥121°C for 30min and all
biological indicators do not show growth).
The sterilisation phase time is not less than 15 minutes for non DoA regulated loads and
temperature regulated cycles.
The measured chamber pressure is within ± 1°C of the mean chamber temperature at the
midpoint of the sterilisation phase.
Mean chamber Temperature = ________oC
Chamber Pressure = _________ kPa Saturation Temperature = _______ oC
Steam Penetration Studies (Load)
A minimum accumulated F0 of 22 minutes is obtained at all load measurement (penetration)
locations at the end of the cooling phase on the autoclave printout (with the exception of F0
regulated cycles which must have a minimum F0 of 15min).
Min F0 Obtained T/C Location
All exposed BIs must test negative for growth, except for the positive control.
Record the greatest load temperature and T/C location °C T/C #:_______
Wet Cycles Only: All liquid volumes are <90ºC ± 1ºC at the end of the cooling cycle.
Dry Cycles Only: The autoclave load is visibly dry. (“visibly dry” being defined as the load
items and all layers of sterile wrapping material are free of pooled liquid upon visual
inspection)
Heat Distribution Studies (Chamber)
The autoclave drain probe achieves a minimum temperature of ≥1oC below the
sterilisation set point temperature. Set Pt. Min. Temp.
The measured temperatures within the chamber are within (+2/-1)°C of the sterilisation
temperature set point.
Lower Upper
Set Point
Temperature Temperature
The measured temperatures of the thermocouples within the chamber are within ±1°C of
the mean chamber temperature at each time point.
Trial Acceptance (Circle) Met Criteria – Pass Did not meet Criteria - Fail
Comments
Acceptance
Criteria
Achieved
(Yes/No/
Accepted Under
Acceptance Criteria Deviation)
Recorded cycle parameters are consistent with programmed cycle parameters.
The Department of Agriculture (DoA) requirements are met for DoA regulated loads (If
load core measured, all points ≥121°C for 15min, else all points ≥121°C for 30min and
all biological indicators do not show growth).
The sterilisation phase time is not less than 15 minutes for non DoA regulated loads
and temperature regulated cycles.
The measured chamber pressure is within ± 1°C of the mean chamber temperature at
the midpoint of the sterilisation phase.
Mean Chamber Temperature = ________oC
Chamber Pressure = _________ kPa Saturation Temperature = _______ oC
All exposed BIs must test negative for growth, except for the positive control.
The autoclave load is visibly dry. (Note-visibly dry is defined as, upon visual inspection
of the load at the end of the cycle, the load items and all layers of wrapping material are
found to be free of pooled liquid).
The measured temperature of the thermocouples within the chamber is within ±1°C of
the mean chamber temperature at each time point.
The measured temperatures within the chamber are within (+2/-1)°C of the
sterilisation set point. Set Point Temp.
Lower Temperature Upper Temperature
The autoclave drain probe achieves a minimum temperature of ≥1oC below the
sterilisation set point. Set Point Min. Temp.
Does this Deviation directly affect product status? Yes No If yes, raise a quality deviation
Deviation ID
A. Identification of the Section of the Protocol Affected
D. Reason (Root Cause) for the Deviation Occurrence and Impact on the Validation Study
F. Attachments
Note: This form may be reproduced in both “hardcopy” and in an electronic format. The authorisation of this form is located
on a separate page to permit reproduction of this form electronically.